GLY-SAL 2-2 PADS- salicylic acid cloth 
Topiderm, Inc.

----------

Gly-Sal® 2-2 Pads

Drug Facts

Active ingredient

Salicylic Acid USP, 2%

Purpose

Acne medication

Uses

Cleansing pads for the treatment of acne.

Directions

Warnings

  • Keep out of reach of children
  • If irritation develops, discontinue use and consult a doctor
  • Using other topical acne medication at the same time or immediately following use of this product may increase dryness or irritation of the skin. If this occurs, only one medication should be used unless directed by a doctor
  • If swallowed, seek professional assistance or contact a Poison Control Center immediately
  • Sunscreen use is recommended with any glycolic acid product and for an additional week thereafter because some individuals may be more sensitive to sunlight.

Inactive Ingredients

Ammonium Hydroxide, Camellia Sinensis Leaf Extract, Disodium EDTA, Glycolic Acid, Hamamelis Virginiana (Witch Hazel) Water, Imidazolidinyl Urea, Polysorbate 20, Purified Water, Sodium Benzoate.

PRINCIPAL DISPLAY PANEL - 60 Pad Jar Label

REPLENiX®
ACNE SOLUTIONS

Topix Pharmaceuticals, Inc.
N. Amityville, NY 11701

Gly/Sal® 2-2
Pads

Glycolic Acid 2%
Salicylic Acid USP, 2%

60 Pads

PRINCIPAL DISPLAY PANEL - 60 Pad Jar Label
GLY-SAL 2-2 PADS 
salicylic acid cloth
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:51326-923
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID20 mg
Inactive Ingredients
Ingredient NameStrength
AMMONIA (UNII: 5138Q19F1X)  
GREEN TEA LEAF (UNII: W2ZU1RY8B0)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
GLYCOLIC ACID (UNII: 0WT12SX38S)  
HAMAMELIS VIRGINIANA TOP WATER (UNII: NT00Y05A2V)  
IMIDUREA (UNII: M629807ATL)  
POLYSORBATE 20 (UNII: 7T1F30V5YH)  
WATER (UNII: 059QF0KO0R)  
SODIUM BENZOATE (UNII: OJ245FE5EU)  
ZINC PIDOLATE (UNII: C32PQ86DH4)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:51326-923-0160 in 1 JAR; Type 0: Not a Combination Product12/16/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph drugM00612/16/2019
Labeler - Topiderm, Inc. (049121643)
Registrant - Topiderm, Inc. (049121643)
Establishment
NameAddressID/FEIBusiness Operations
Topiderm, Inc.049121643MANUFACTURE(51326-923)
Establishment
NameAddressID/FEIBusiness Operations
Topix Pharmaceuticals, Inc.117745066PACK(51326-923)

Revised: 2/2023
Document Id: 45299656-b734-4edb-a780-e99a5a333043
Set id: a92a9ffb-5c5b-43a4-b669-04667324920b
Version: 2
Effective Time: 20230216
 
Topiderm, Inc.